Human Insulin Market by Drugs & Applications Human Insulin Market by Drugs & Applications | Page 25
SAMPLE TABLES
TABLE 1 LONG-ACTING INSULIN ANALOGS AND BIOSIMILARS MARKET SIZE,
BY REGION, 2013–2020 (USD MILLION)
2013 2014 2015-e 2020-p CAGR
(2015–2020)
NORTH AMERICA xx.x xx.x xx.x xx.x xx.x %
EUROPE xx.x xx.x xx.x xx.x xx.x %
ASIA-PACIFIC xx.x xx.x xx.x xx.x xx.x %
ROW xx.x xx.x xx.x xx.x xx.x %
TOTAL xx.x xx.x xx.x xx.x xx.x %
REGION
Sources: WHO, OECD, EHN, the World Bank, U.S. Census Bureau, Offices of National Statistics (U.K.), Annual Reports, SEC Filings, Press Releases, Investor Presentations, Journals, Expert Interviews, and
MarketsandMarkets Analysis
TABLE 2 U.S.: HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT,
2013–2020 (USD MILLION)
2013 2014 2015-e 2020-p CAGR
(2015–2020)
INSULIN ANALOGS & BIOSIMILARS xx.x xx.x xx.x xx.x xx.x %
HUMAN INSULIN BIOLOGICS xx.x xx.x xx.x xx.x xx.x %
TOTAL xx.x xx.x xx.x xx.x xx.x %
PRODUCT
Sources: WHO, OECD, EHN, the World Bank, U.S. Census Bureau, Annual Reports, SEC Filings, Press Releases, Investor Presentations, Journals, Expert Interviews, and MarketsandMarkets Analysis
TABLE 3
EUROPE: HUMAN INSULIN MARKET SIZE, BY COUNTRY, 2013–2020 (USD MILLION)
2013 2014 2015-e 2020-p CAGR
(2015–2020)
GERMANY xx.x xx.x xx.x xx.x xx.x %
FRANCE xx.x xx.x xx.x xx.x xx.x %
U.K. xx.x xx.x xx.x xx.x xx.x %
ROE xx.x xx.x xx.x xx.x xx.x %
TOTAL xx.x xx.x xx.x xx.x xx.x %
COUNTRY/REGION
Sources: WHO, OECD, EHN, the World Bank, Offices of National Statistics (U.K.), Annual Reports, SEC Filings, Press Releases, Investor Presentations, Journals, Expert Interviews, and MarketsandMarkets
Analysis
[email protected]
www.marketsandmarkets.com
25